Trending Topic

Inflammation of the breast in women. Female breasts with signs of the disease. A low-poly construction of interconnected lines and points. Blue background.
5 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
Mohammad Ammad Ud Din, Hania Liaqat, Ayesha Tayyab

The incidence rate of breast cancer (BC) is the highest in Pakistan among all Asian countries.1 In 2018 alone, 2.1 million cases were diagnosed, although the exact number is likely much higher due to poor reporting in rural areas and the lack of a formal national cancer registry.1,2 Over the last decade, multiple non-governmental organizations and large […]

Shibani Nicum, ESMO 2021: First Results of the OCTOVA Trial

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Oct 5th 2021

touchONCOLOGY joins Dr Shibani Nicum (University College London, UK) at ESMO 2021 to present the first results of the OCTOVA trial of olaparib compared to weekly paclitaxel or olaparib plus cediranib in patients with platinum-resistant ovarian cancer.

Questions
1. What are the unmet needs in the treatment of ovarian cancer patients who relapse within 12 months of platinum-based chemotherapy? 00:18-01:00)
2. What is the rationale for combining olaparib and cediranib in this indication? (01:08-02:26)
3. Could you tell us a little about the aims, design and patient stratification of the OCTOVA trial? (02:26-03:55)
4. What were the efficacy and safety findings of the trial? (03:55-05:42)
5. What were the conclusions of the investigators, and what future studies are planned? (05:42-06:30)

Disclosures: Shibani Nicum disclosures consulting and advisory services, speaking or writing engagements, public presentations for AstraZeneca, GSK and Clovis, and academic funding from AstraZeneca.

Support: Interview and filming supported by Touch Medical Media. Interview conducted by Sophie Nickelson.

Filmed in coverage of the ESMO 2021 Annual Meeting.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied

This Functionality is for
Members Only

Explore the latest in medical education and stay current in your field. Create a free account to track your learning.

Close Popup